151620-69-8

Basic information

• Product Name: 3-amino-1-N-(2-cyclopentylethyl)-2,4-dioxo-5-N-(2-fluorophenyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine
• CAS NO: 151620-69-8
• Molecular Weight: 381.45
• Mol File: 151620-69-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-amino-1-N-(2-cyclopentylethyl)-2,4-dioxo-5-N-(2-fluorophenyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-amino-1-N-(2-cyclopentylethyl)-2,4-dioxo-5-N-(2-fluorophenyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine(151620-69-8)
• EPA Substance Registry System: 3-amino-1-N-(2-cyclopentylethyl)-2,4-dioxo-5-N-(2-fluorophenyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine(151620-69-8)

Safety Data

• Hazardous Substances Data: 151620-69-8(Hazardous Substances Data)

Upstream product

• 151386-28-6 2-(2-cyclopentylethyl)amino-2'-fluorodiphenylamine 
• 28898-03-5 N-(2-fluorophenyl)benzene-1,2-diamine 
• 151386-29-7 1-N-(2-cyclopentylethyl)-2,4-dioxo-5-N-(2-fluorophenyl)-3-phenylhydrazono-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine 
• 5623-81-4 2-cyclopentylacetaldehyde 

Downstream Products

• 153930-53-1 1-(2-cyclopentylethyl)-2,4-dioxo-5-(2-fluorophenyl)-3-isocyanato-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine 

Relevant articles and documents

Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazephines as cholecystokinin-B receptor antagonists

A series of 5-phenyl-3-ureidobenzodiazepine-2,4-diones was synthesized and evaluated as cholecystokinin-B (CCK-B) receptor antagonists. Structure-activity relationship (SAR) studies revealed the importance of the N-1 substituent for potent and selective C